SB 1711, the “Safeguarding Transit Operations to Prohibit China Act” or “STOP China Act,” would restrict the use of federal funds for the procurement of certain vehicles and vehicle technologies tied to entities based in covered nations, with the bill’s findings and operative provisions focused primarily on the People’s Republic of China. The bill states that PRC-developed technologies in vehicles pose national security risks, that PRC industrial policy distorts markets, and that U.S. taxpayer dollars should not support PRC-subsidized vehicle manufacturing or technology companies.
The bill amends federal transit law to bar the Secretary of Transportation from awarding or obligating covered funding for contracts or subcontracts to procure “covered vehicles,” including rolling stock and vehicles that incorporate certain electric power trains produced by covered entities. It also prohibits funding for related bus charging or fueling infrastructure when the bus was procured under a covered contract. In addition, it directs the U.S. Trade Representative, in consultation with the Attorney General and the Secretary of Transportation, to publish and regularly update a public list of covered entities whose vehicles or electric power trains trigger the prohibition. Separate provisions extend similar restrictions to other Department of Transportation appropriations outside chapter 53 of title 49.
The bill includes narrow exceptions allowing procurement or infrastructure work for vehicle inspection, investigation, and motor vehicle safety research, development, or testing. It also contains transition language allowing completion of certain preexisting contracts and a severability clause. Overall, the measure would tighten federal procurement rules affecting transit agencies, the Department of Transportation, and suppliers of rail rolling stock and related vehicle technologies linked to covered nations.
Because the bill was only introduced and referred to committee, there is no recorded vote or committee transcript in the provided materials. The available context suggests the bill is framed as a national security and supply-chain protection measure, with bipartisan-looking sponsorship, but no formal legislative debate or recorded opposition is available here. The main policy tension inherent in the bill is between national security concerns and the practical effects on transit procurement, existing contracts, and the availability of vehicle suppliers and technologies.
SB 1711 would amend section 5323(u) of title 49, United States Code, and add a new DOT-wide funding restriction, creating a federal procurement ban on certain vehicles and vehicle technologies associated with covered entities in covered nations. It would affect transit funding, rolling stock procurement, bus infrastructure projects, and related federal transportation spending by limiting which vendors and technologies can receive covered funds. The bill would also require the U.S. Trade Representative to maintain a public list of covered entities, shaping compliance obligations for federal agencies, transit authorities, contractors, and suppliers.
The bill’s stated purpose and sponsor lineup indicate a generally supportive, security-focused posture toward restricting PRC-linked vehicle procurement. The text frames the issue as a national security and economic competitiveness concern, and the absence of recorded votes or hearings means there is no documented formal opposition in the provided record. Based on the bill language alone, the sentiment appears strongly precautionary and anti-PRC in procurement policy, with emphasis on protecting U.S. transit systems and supply chains.
The central point of contention is likely whether broad federal procurement restrictions are necessary and how far they should reach. Supporters would emphasize national security, protection against foreign influence, and reducing dependence on PRC-linked suppliers, while critics might argue the definitions are expansive, could disrupt transit projects, and may raise costs or limit vendor options. Another likely issue is the treatment of existing contracts and the scope of the exceptions for safety research and testing, which attempt to preserve limited operational flexibility while still imposing a broad prohibition.